Cargando…
Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882237/ https://www.ncbi.nlm.nih.gov/pubmed/35220661 http://dx.doi.org/10.1002/ctm2.732 |
_version_ | 1784659649137475584 |
---|---|
author | Ju, Bin Zhou, Bing Song, Shuo Fan, Qing Ge, Xiangyang Wang, Haiyan Cheng, Lin Guo, Huimin Shu, Dan Liu, Lei Zhang, Zheng |
author_facet | Ju, Bin Zhou, Bing Song, Shuo Fan, Qing Ge, Xiangyang Wang, Haiyan Cheng, Lin Guo, Huimin Shu, Dan Liu, Lei Zhang, Zheng |
author_sort | Ju, Bin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8882237 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88822372022-03-02 Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine Ju, Bin Zhou, Bing Song, Shuo Fan, Qing Ge, Xiangyang Wang, Haiyan Cheng, Lin Guo, Huimin Shu, Dan Liu, Lei Zhang, Zheng Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2022-02-27 /pmc/articles/PMC8882237/ /pubmed/35220661 http://dx.doi.org/10.1002/ctm2.732 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to Editor Ju, Bin Zhou, Bing Song, Shuo Fan, Qing Ge, Xiangyang Wang, Haiyan Cheng, Lin Guo, Huimin Shu, Dan Liu, Lei Zhang, Zheng Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine |
title | Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine |
title_full | Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine |
title_fullStr | Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine |
title_full_unstemmed | Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine |
title_short | Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine |
title_sort | potent antibody immunity to sars‐cov‐2 variants elicited by a third dose of inactivated vaccine |
topic | Letter to Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882237/ https://www.ncbi.nlm.nih.gov/pubmed/35220661 http://dx.doi.org/10.1002/ctm2.732 |
work_keys_str_mv | AT jubin potentantibodyimmunitytosarscov2variantselicitedbyathirddoseofinactivatedvaccine AT zhoubing potentantibodyimmunitytosarscov2variantselicitedbyathirddoseofinactivatedvaccine AT songshuo potentantibodyimmunitytosarscov2variantselicitedbyathirddoseofinactivatedvaccine AT fanqing potentantibodyimmunitytosarscov2variantselicitedbyathirddoseofinactivatedvaccine AT gexiangyang potentantibodyimmunitytosarscov2variantselicitedbyathirddoseofinactivatedvaccine AT wanghaiyan potentantibodyimmunitytosarscov2variantselicitedbyathirddoseofinactivatedvaccine AT chenglin potentantibodyimmunitytosarscov2variantselicitedbyathirddoseofinactivatedvaccine AT guohuimin potentantibodyimmunitytosarscov2variantselicitedbyathirddoseofinactivatedvaccine AT shudan potentantibodyimmunitytosarscov2variantselicitedbyathirddoseofinactivatedvaccine AT liulei potentantibodyimmunitytosarscov2variantselicitedbyathirddoseofinactivatedvaccine AT zhangzheng potentantibodyimmunitytosarscov2variantselicitedbyathirddoseofinactivatedvaccine |